Non-invasive monitoring of pancreatic tumor progression in the RIP1-Tag2 mouse by magnetic resonance imaging
- PMID: 22752651
- DOI: 10.1007/s11307-012-0548-0
Non-invasive monitoring of pancreatic tumor progression in the RIP1-Tag2 mouse by magnetic resonance imaging
Abstract
Purpose: Assessing information on tumor progression in the RIP1-Tag2 mouse in vivo is a great challenge because the tumors form spontaneously throughout the pancreas and are difficult to detect with current imaging modalities. In this study, we focused on non-invasive magnetic resonance imaging, providing information on tumor growth.
Procedures: Tissue relaxation times were measured over time and were compared between tumors and healthy pancreatic tissue. The effects of age and body temperature on these relaxation times, possibly influencing image contrast and therefore detection capabilities, were evaluated.
Results: Tumors appeared hyperintense in T2-weighted images when they exceeded 0.8 mm in diameter, and both relaxation times showed significantly higher values in tumors than in the healthy pancreas.
Conclusion: Visualization and monitoring of these small tumors in vivo is feasible, even under adverse conditions of permanent gut movement. In the mouse model studied, the relaxation times of tumors differed significantly from healthy pancreatic tissue.
Similar articles
-
¹H NMR based serum metabolic profiles associated with pathological progression of pancreatic islet β cell tumor in Rip1-Tag2 mice.Int J Biol Sci. 2015 Apr 5;11(5):595-603. doi: 10.7150/ijbs.11058. eCollection 2015. Int J Biol Sci. 2015. PMID: 25892966 Free PMC article.
-
Magnetic resonance imaging of the pancreas and pancreatic tumors in a mouse orthotopic model of human cancer.Int J Cancer. 2003 Sep 20;106(5):806-11. doi: 10.1002/ijc.11281. Int J Cancer. 2003. PMID: 12866043
-
Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive in vivo18F-FDG-PET.Theranostics. 2020 Jan 1;10(2):925-937. doi: 10.7150/thno.35989. eCollection 2020. Theranostics. 2020. PMID: 31903160 Free PMC article.
-
MR imaging techniques for evaluation of the pancreas.Top Magn Reson Imaging. 1996 Oct;8(5):248-64. Top Magn Reson Imaging. 1996. PMID: 8914225 Review.
-
Mangan-enhanced MR imaging for the detection and localisation of small pancreatic insulinoma.Eur Radiol. 2004 May;14(5):923-5. doi: 10.1007/s00330-003-2017-2. Epub 2003 Sep 3. Eur Radiol. 2004. PMID: 12955450 Review.
Cited by
-
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.Nature. 2015 Jul 9;523(7559):177-82. doi: 10.1038/nature14581. Epub 2015 Jun 24. Nature. 2015. PMID: 26106858 Free PMC article.
-
Adaptive design of mRNA-loaded extracellular vesicles for targeted immunotherapy of cancer.Nat Commun. 2023 Oct 19;14(1):6610. doi: 10.1038/s41467-023-42365-5. Nat Commun. 2023. PMID: 37857647 Free PMC article.
-
Feasibility of sequential PET/MRI using a state-of-the-art small animal PET and a 1 T benchtop MRI.Mol Imaging Biol. 2013 Apr;15(2):155-65. doi: 10.1007/s11307-012-0577-8. Mol Imaging Biol. 2013. PMID: 22811019
-
Natural killer cell-based adoptive transfer immunotherapy for pancreatic ductal adenocarcinoma in a KrasLSL-G12D p53LSL-R172H Pdx1-Cre mouse model.Am J Cancer Res. 2019 Aug 1;9(8):1757-1765. eCollection 2019. Am J Cancer Res. 2019. PMID: 31497356 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous